welcome to oneGRAVESvoice- a positively charged Graves' disease and thyroid eye disease community.
- join today!
- log in
The EveryLife Foundation for Rare Diseases will convene its 12th annual Scientific Workshop to highlight and document the COVID-19 mitigation strategies being utilized by industry partners and rare disease communities in an effort to move towards permanent solutions.
The goal of this year’s workshop is to gather key thought-leaders from the FDA, NIH, CMS, industry, patient organizations and other relevant stakeholder groups to highlight case studies of COVID-19 innovations, discuss potential longer-term models and best practices, and to identify how together, we can carve the pathway forward.
Tuesday, December 15, 2020
10:00 AM – 3:15 PM
The event has ended.
Thyroid Awareness MonthJanuary is celebrated as Thyroid Awarene...
Hyperthyroidism and Your HeartHyperthyroidism occurs when your thyroid...
Review of the Literature and Report of a Large Series of Patients Regarding the Association of Other Autoimmune Dise...Several studies have reported an associa...
Thyroid-Associated Ophthalmopathy After Treatment for Graves’ Hyperthyroidism With Antithyroid Drugs or Iodine...Context: Previous randomized trials hav...
Coronavirus Preparedness for People with Chronic Diseaseshttps://www.youtube.com/watch?v=G_JC3vUT...
Effects of Selenium on Short-Term Control of Hyperthyroidism due to Graves’ Disease Treated With Methimazole: ...Objective: In spite of previous conflic...
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thy...Background: Thyrotoxicosis has multip...